TITUS BRIAN sold 26,560 shares of CTVA at $63.74 on 2025-02-20, reducing holdings 70.1%; stock at -5.4% from 52-week high amid negative earnings.
TITUS BRIAN executed a substantial reduction in his CTVA position, selling 26,560 shares (representing a net change of -70.1% of pre-transaction holdings) at $63.74. The timing coincides with the company's recent operating pressure: latest quarterly revenue is $2,326,000,000 with a net loss of $524,000,000, and full-year revenue declined -1.8% year-over-year. The stock currently trades at $62.61, near the lower end of its 52-week range and -5.4% from its 52-week high. With a 49.69 P/E ratio on negative earnings, the company faces valuation and fundamental headwinds. This large proportional reduction by an insider warrants examination of whether it reflects a reassessment of Corteva's near-term prospects or merely a liquidity event.